Cytoreductive surgery with or without perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis: Our initial experience

Abstract

Aim: We studied to present our initial experience of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy(HIPEC) or early postoperative intraperitoneal chemotherapy (EPIC) in the treatment of peritoneal carcinomatosis.Material and Methods: The results of 20 consecutive patients treated with CRS±HIPEC or EPIC for peritoneal carcinomatosis in ourhospital between November 2014 and February 2019 were evaluated retrospectively. Demographic, clinical and histopathologicaldata of the patients were analyzed. The patients were also divided into two groups as PCI score 0.05).Conclusion: Cytoreductive surgery and intraperito